Straits Times Index
3,290.69 +24.74 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,942.47 +404.66 (+2.18%) FTSE 100
8,381.35 +27.30 (+0.33%) Bitcoin USD
63,009.61 +1,477.08 (+2.40%) CMC Crypto 200
1,351.78 -6.23 (-0.46%)
PHAT May 2024 15.000 put
| Previous close | 7.50 |
| Open | N/A |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 15.00 |
| Expiry date | 2024-05-17 |
| Day's range | 7.50 - 7.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksPhathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Lags Revenue Estimates
Phathom Pharmaceuticals (PHAT) delivered earnings and revenue surprises of 0.70% and 30.73%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswirePhathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Over 17,500 total prescriptions for VOQUEZNA® products have been dispensed, launch-to-date, a 361% increase since last quarterly report Net revenues of $1.9 million reported for the first full quarter of launch Cigna Healthcare recently added VOQUEZNA tablets to its formularies, broadening coverage to approximately 48% of all U.S. commercial lives National direct-to-consumer campaign, “VOQUEZNA Can Kick Some Acid,” underway across broadcast and streaming TV Management to host conference call tod
- GlobeNewswire
Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024
Management to host conference call on Thursday, May 9, 2024, at 8:30 a.m. ET FLORHAM PARK, N.J., April 29, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today announced that it will host a live webcast at 8:30 am ET on Thursday, May 9, 2024, to report its first quarter 2024 financial results and provide an update on business progress. A live webcast and a
